Summary
This multi-institutional cohort study investigated FGFR3 mutation prevalence and expression patterns in bladder cancer patients treated by radical cystectomy, as suggested by the title. The findings appear intended to inform clinical decision-making regarding patient selection for anti-FGFR3 targeted therapies. The work is oncology-focused rather than relevant to food systems, farming or soil health.
UK applicability
This is a basic oncology research study on bladder cancer molecular biology and has no direct applicability to UK farming systems, soil health or nutritional outcomes. It does not fall within Vitagri's Pulse Brain remit.
Key measures
FGFR3 mutation status, FGFR3 protein expression levels, clinicopathological outcomes in radical cystectomy patients
Outcomes reported
The study examined FGFR3 mutation status and protein expression levels in a large cohort of bladder cancer patients who underwent radical cystectomy, with implications for patient selection for anti-FGFR3 targeted therapies.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.